The Best Fundamental Analysis Tools for Indian Stocks (2026)

The best fundamental analysis tool for Indian stocks depends on what you do: Screener.in is the default free workhorse for financials and screening, Tijori is strong on segment and operational data, Trendlyne leads on broker estimates and scores, TIKR is a global terminal that also covers India, and Altys is an India-first research terminal built for professionals, currently in private preview. There is no single winner. The right tool is the one that answers your questions accurately, with numbers you can trace back to a filing.

Fundamental analysis is really four jobs: reading the statements, computing the ratios, screening the universe, and understanding the business through filings and earnings calls. Each tool below is good at some of these and lighter on others. Below is what each one actually does, verified from their current public information, and who it fits.

At a glance

Tool	Best at	India coverage	Rough cost	Fits
Screener.in	Financials, ratios, custom screens	India-only, deep	Free; Premium about ₹4,999/year	Almost everyone
Tijori Finance	Segment, operational, alt data	India-only, deep	Free tier; about ₹3,500/year	Business-model diggers
Trendlyne	Broker estimates, scores, concall summaries	India-only, broad	GuruQ about ₹2,090/year	Estimate and momentum users
TIKR	Global fundamentals and estimates	Global, India included	Roughly $10-50/month	Global and India together
Altys	India-first, point-in-time, source-linked	India-only, deep	Private preview (invite)	PMS, AIF, family offices, MFDs

Prices and features change, so treat this as a starting map, not gospel.

Screener.in: the default starting point

Screener.in, founded in 2009, is the tool most Indian investors reach for first, and for good reason. It covers roughly 4,000 NSE and BSE companies with 10-plus years of P&L, balance sheet, and cash flow data, updated within days of filings. You get standard ratios, a flexible screener where you can write custom queries and even build custom ratios, watchlists with alerts, peer comparison, shareholding patterns, and links to primary documents like annual reports and concall transcripts.

It is free for the core experience, and the Premium “Active Investor” plan (around ₹4,999 a year) adds CSV and Excel exports, shareholder search, and custom support. For learning the statements, running a first screen, or checking a familiar company, Screener is hard to beat on value. If you want to go further, our guide on what ROCE actually tells you pairs well with the ratio views Screener gives you.

Where it is deliberately simple: it is not built for backtesting a strategy, reconstructing exactly what was known on a past date, or heavy institutional workflows. For most individual investors, that simplicity is a feature.

Tijori Finance: segment and operational depth

Tijori Finance covers similar ground on financials but is best known for going one layer deeper into how a business runs. It surfaces segment-wise revenue, product and geography revenue mix, capacity and operational metrics, market share, raw material price trends, and supply-chain links, largely drawn from company annual reports. It also includes the standard statements plus tools like a reverse DCF.

This makes Tijori especially useful when you want to understand the drivers behind the numbers, not just the numbers. If you are trying to map a company’s revenue to its actual products and geographies, our explainer on revenue mapping describes the same discipline Tijori’s visualisations support. Tijori offers a limited free tier, with historic data and its full metric set unlocking on a paid plan (around ₹3,500 a year). Tijori has also launched an AI product suite, Tijori Stack, adding concall monitoring, on-demand company reports, and a filings-grounded question-and-answer layer; we cover it in our note on Tijori Stack, alongside the standalone Tijori Finance view.

The trade-off is scope. Tijori is a data and visualisation tool for understanding businesses, not a forecasting or backtesting workbench.

Tickertape: scorecards and screening in one place

Tickertape by smallcase is a widely used markets analytics platform that many investors use for fundamental work. It offers stock and mutual-fund screeners, a company “scorecard” that summarises performance, valuation, growth, profitability, and red flags, a Market Mood Index, and portfolio analytics. Its coverage spans stocks, ETFs, and mutual funds, which makes it a convenient single place for a first read on a company or fund.

As with any summary-led tool, the scorecards and ratings are a starting point rather than a substitute for reading the filings yourself. If you are weighing Tickertape for professional or point-in-time work, our Tickertape view for research desks walks through where those needs are met differently.

Trendlyne: estimates, scores, and alerts

Trendlyne is the broadest of the India-first tools on breadth of signals. Its headline features are the DVM scores, which rate every stock 0 to 100 on Durability, Valuation, and Momentum, and its Forecaster, which aggregates consensus estimates from a large set of brokerages, including price targets and revenue, EPS, and profit projections, with analyst accuracy tracking. It also offers AI-generated summaries of earnings-call transcripts, a very large screener parameter set, portfolio sync from Indian brokers, alerts, and backtests. Popular plans run from roughly ₹2,090 to ₹5,900 a year.

For an investor who wants to see where the street sits and get notified when things change, Trendlyne is strong, and our Trendlyne view for professional workflows covers where a heavier terminal takes over. If you want to go beyond the AI summary and work a transcript yourself, our piece on reading a concall like an analyst is a useful companion. The caution with any consensus-and-scores tool is to treat estimates and scores as inputs, not answers, and to verify the underlying figures against the filings.

TIKR: a global terminal that reaches India

TIKR Terminal is not India-first, but it is worth knowing. It provides full financial statements, a wide set of valuation multiples, analyst consensus estimates with multi-year forecasts, transcripts, filings, and ownership data across more than 100,000 companies in dozens of countries, powered by S&P Capital IQ data. Indian listings are included in that global set. Pricing is modest for what it offers, roughly $10 to $50 a month depending on tier.

TIKR fits an investor who follows both global and Indian names and wants one consistent interface across them. The honest limitation for a purely India-focused user is that India is one market among many here. Local-specific depth, such as granular Indian shareholding detail, concall coverage, and estimate breadth for smaller Indian companies, is generally lighter than what the India-only tools provide.

Altys: India-first, point-in-time, source-linked

Altys is an equity research and fundamental analysis platform built specifically for Indian stocks (NSE and BSE) and Indian mutual funds, aimed at professional users such as PMS firms, AIFs, family offices, and MFDs. It is currently invite-only, in private preview, so it is not something you can simply sign up for today.

What it focuses on is different from the tools above in a few concrete ways. It brings company filings, concall transcripts, management guidance, shareholding, macro series, FII and DII flows, factor scores, and mutual-fund data into one place, then adds tools to screen, build financial models, forecast, and backtest a strategy. Its design choices are the distinguishing part: numbers are calculated from the company’s own filings and every figure links back to its source document, line, and date, so a value can be traced and checked. It also keeps data point-in-time, meaning it stores what was known on each past date rather than today’s restated view, which matters for honest backtests. Our note on why point-in-time data matters explains that idea, and the same source-linked discipline underpins work like finding problems before the market does.

Altys is not a broker, not a tip service, and not a SEBI-registered research analyst or adviser. It does not tell you what to buy or sell. It is a research workbench, and because it is in private preview, it fits professional teams evaluating a purpose-built India tool rather than individual investors who need something available immediately.

Which one fits you

• If you are learning or want a free, reliable default: start with Screener.in. It covers the statements, ratios, and screening that most fundamental work needs.
• If you want to understand the business behind the numbers: Tijori’s segment and operational data is the differentiator.
• If you care about the street’s view and change alerts: Trendlyne’s estimates, scores, and concall summaries are built for that.
• If you follow global and Indian names together: TIKR gives you one interface across markets, with India included.
• If you are a professional who needs point-in-time, source-linked data with modelling and backtesting: Altys is built for that use, subject to its private-preview access.

Many serious investors use more than one. A common pattern is Screener or Tijori for day-to-day fundamentals, Trendlyne for estimates, and a heavier terminal when the work demands audit trails and historical accuracy. Whichever you choose, run the same test: pick a few Indian companies you know well, check the numbers against the filings, and see how quickly you can trace a single figure back to its source. If you are weighing the free-tool tier against a professional one, our companion piece on Screener.in and beyond walks through where that line sits.

For adjacent angles, see our roundups of the best equity research tools in India and the best AI research tools for Indian stocks, our explainer on the AI stock screeners now available for India, and, if funds are part of your work, the best mutual-fund research tools in India.

This article is about research tools, not securities. It is educational and does not contain investment advice or stock recommendations. Altys Labs is not a registered Research Analyst or Investment Adviser.